Insmed (NASDAQ:INSM – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a report issued on Tuesday. A number of other equities research analysts also recently weighed in on INSM. Wolfe Research started coverage on Insmed in a report on Thursday, February 15th. They issued […]